About Tim Kopatich
Form D filings for Cellebration Life Sciences from 2021 to 2023 list Tim Kopatich as CEO.
Tim Kopatich first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Tim Kopatich in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tim Kopatich works with at each company, as listed on that company's latest Form D.
Cellebration Life Sciences, Inc. · Form D/A, Aug 21, 2023